BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2004
View Archived Issues
Enrollment completed in phase IIb trial of AOD-9604 for obesity
Read More
Approvable letter for RSR-13
Read More
Urotensin-II receptor antagonist effective against renal ischemia in vivo
Read More
Novel PARP inhibitor attenuates neuronal damage in in vivo models of cerebral ischemia
Read More
Novel compound by Chugai boosts chondrogenesis in vitro and in vivo
Read More
Synthetic N-acylated glucosamines promising for treatment of arthritis
Read More
Anti-IL-13 antibody with potential for the treatment of asthma
Read More
Encysive to retain Thelin marketing rights
Read More
Not approvable letter for proposed Angiomax label amendment
Read More
XL-647 advances into phase I
Read More
GenoMed expands trials into viruses that cause hemorrhagic fever
Read More
Abbott to reacquire rights to trandolapril from Aventis
Read More
Probuphine completes pilot study for opiate addiction
Read More
European MAA submission for Antegren for MS
Read More
Transform collaborates with Abbott to enhance drug development programs
Read More
Cerylid Biosciences completes transaction to acquire Kinacia
Read More
Toyama Chemical commences clinical study with T-817
Read More
Amgen Q1 highlighted by approval of Sensipar
Read More
Guilford updates Q1 progress
Read More
R&D programs at Galen continue to advance during first half of 2004
Read More
Vitamin C disappoints in diabetes study
Read More
KF-19514 ameliorates asthma parameters in vivo
Read More
Rhinovirus infection blocked by lansoprazole
Read More
Brigham and Women's Hospital and Prous Science sign agreement to launch Global Grand Rounds
Read More
BCX-2798 and BCX-2855 show efficacy against human parainfluenza viruses
Read More
The antidiabetic agent BLX-1002 subject of various presentations at ADA
Read More
Retinoid X receptor antagonist improves glucose and lipid metabolism in vivo
Read More
Agonistic antibodies to Epo receptors and their use as antianemic agents
Read More
Anti-GDF-8 antibodies and their use patented by Wyeth and Cambridge Antibody Technology
Read More
Anti-IFN-gamma antibodies developed by scientists at Amgen and Medarex
Read More
Abbott claims three series of compounds for epilepsy, migraine and bipolar disorder
Read More
Amersham patent covers targeted Tc complexes as MRI agents
Read More